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ABSTRACT
This report is the second in a series of research summaries produced in connection with the operations research
project, Enhancing Access to Family Planning Services through the Introduction of Emergency Contraception.
Launched in September 1997, the project explores the many issues surrounding to the introduction and delivery of
emergency contraception services in a developing country context.
The study described in this report compares two different approaches to overcoming barriers that prevent women
from accessing emergency contraception during the 72 hour period when the first dosage of emergency
contraception pills (ECPs) must be taken. In one approach, new family planning acceptors were given a pack of
ECPs for later use in the event of method failure, rape, or unprotected sex. In the other approach, acceptors were
given an advanced prescription which, if necessary, could be redeemed for an actual pack of ECPs at
participating health centers. Implemented at four public sector clinics in Lusaka, Zambia, the strategies are
compared in terms of their effectiveness at communicating appropriate information on emergency contraception;
reducing wastage of ECPs; facilitating timely access to emergency contraception; and limiting use of emergency
contraception for emergencies only. The study adopted an experimental design using three equivalent groups:
two experimental (one for each intervention) and one control. Each group consisted of 150 new acceptors of the
pill and 150 new acceptors of the condom as their exclusive family planning method
On the issue of communicating appropriate information, study results suggest few appreciable differences
between the two intervention strategies. Both strategies were equally likely to enhance recall of the time frame
within which emergency contraception must be initiated; the number of ECPs needed; the frequency with which
they should be taken; the brand-name of the emergency contraception pill; and the location where it could be
obtained. What these findings suggest, therefore, is that fears over inadequate client knowledge or potential
recall should not serve as a basis for doubting the safety or practicality of dispensing ECPs, either
prophylactically or under advanced prescription.
With respect to product wastage, direct comparisons were complicated by the fact that one strategy entailed the
distribution of actual ECPs, while the other involved the delivery of prescriptions only. Any assessment of
outcomes, therefore, hinged on the relative importance attributed to losses to the service delivery system as
opposed to product loss by individuals. On the side of prophylactic provision, actual individual loss was fairly
minimal. Only about 10 percent of the women who did not use their prophylactically-provided ECPs, for
example, had actually lost them. But because fewer than half the prophylactic recipients of emergency
contraception ever used ECPs, loss to the system (of unused packets) was indeed significant. Advance
prescription, by contrast, saw higher losses of the prescription cards themselves. But because those who
eventually redeemed their prescriptions actually used the product, the loss to the system was minimal.
With regards to timeliness of access, prophylactic administration of ECPs dramatically reduced the length of
time between unprotected sex and the administration of the first dose of pills. Almost half of emergency
contraception users who received their pills prophylactically had taken their first pills within 12 hours of
unprotected sex. The impact of this increased access may even be more significant given recent data suggesting
that emergency contraception is more effective at preventing pregnancy the earlier the pills are taken. The
advanced prescription intervention, by contrast, had virtually no effect at decreasing the timeliness of access.
Two factors may have accounted for this. One was the study’s client base, which underrepresented the
categories of women (young, unmarried women) most likely to value the additional privacy associated with
anonymous prescription cards. The other may have been the narrow scope and inconsistent application of the
intervention itself.
Perhaps the most critical issue addressed during this study, however, was whether increased access to ECPs
encouraged its use for reasons other than “emergencies”. A comparison of the two strategies showed that women
with prior access to ECPs were indeed over three times more likely to use them than those who received
prescriptions. Two reasons accounted for this discrepancy. First, poor contraceptive use among all study
participants suggests that at least some percentage of emergency contraception use had nothing to do with the
prophylactic provision. In such cases, the only advantage to accrue to those who received pills prophylactically
would have been their ability to react more quickly to the consequences of unprotected sex.
But it was clear that prophylactic provision of ECPs could also change the environment within which
contraceptive decisions were made. In some cases, it created new pressures (such as enhancing men’s ability to

negotiate condom use); and in others it made it easier to respond to those pressures by abandoning routine
methods in favor of ECPs. Prophylactic provision also seemed to draw increased attention to the perceived
inconveniences of other hormonal methods – particularly the pill. In such cases, prophylactic provision of ECPs
clearly did lead to non-use of routine family planning methods.
Prophylactic provision of dedicated ECPs can be a safe and effective approach for enhancing access to the
method. Realistically speaking, however, it is not an approach that is ever likely to be applied routinely to all
new family planning acceptors. What this study advocates, therefore, is greater provider-awareness of the usedynamics of emergency contraception so that when prophylactic provision is requested or deemed appropriate, it
can be used more effectively. Training and other informational materials must be candid about the “unintended
consequences” of prophylactic provision so providers are better able to anticipate how the method is likely to be
used. They must also be better informed if they are expected to minimize the factors that have often led to its
unnecessary use: unrealistic perceptions about its efficacy; the belief that emergency contraception represents a
practical alternative to negotiating condom use; or even the notion that all acts of unprotected sex present the
same risk of pregnancy and therefore must be followed by emergency contraception.
The study also recommends, however, that the role of advanced prescription be further explored, particularly
since it has the potential of offering many of the advantages of prophylactic distribution, but at a considerably
lower cost to the system. It can reduce the timeframe between unprotected sex and the first dosage of emergency
contraception pills by eliminating the need for counseling precisely when time is at a premium. It offers privacy
insofar as it avoids the potential embarrassment of having to “explain oneself” before a health care provider. It
eliminates wastage to the service delivery system since the method itself is only distributed when needed. And
because the cost of the cards is marginal, advanced prescription could be routinely implemented for all new
condom and pill users – at least those within easy reach of a chemist, dispensary or other outlet of contraceptive
products.
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INTRODUCTION
This report is the second in a series of research summaries produced in connection with the
operations research project, Enhancing Access to Family Planning Services through the
Introduction of Emergency Contraception (Ahmed et al 1998). Launched in September 1997,
the project explores the broad range of issues surrounding the introduction and delivery of
emergency contraception services in a developing country context.1 The first phase of the
project, which concluded in March 1998, was an exploratory exercise, designed to identify
strategies for overcoming difficulties associated with the introduction of emergency
contraception. The second phase, now underway, uses operations research to test the
problem-solving strategies identified in Phase One.
The study described in this report is the first to be carried out under the project’s second
phase. Initiated in April 1998 and completed nine months later, the study tests the efficacy
and viability of two different approaches to overcoming barriers that prevent women from
accessing emergency contraception within 72 hours -- the period within which the initial dosage
of emergency contraception pills must be taken. Implemented at four public sector clinics in
Lusaka, Zambia, the study compared prophylactic distribution with advanced prescription of
emergency contraception pills. The strategies were compared in terms of their effectiveness at
communicating appropriate information on emergency contraception; reducing wastage of
emergency contraception pills; facilitating timely access to emergency contraception; and
limiting use of emergency contraception for emergencies only.
This report is divided into four major sections. The first recounts the events and
circumstances that led to the development of this study; it details the interventions tested; and
it describes the rationale underlying the selection of these particular interventions. The
second section follows with a summary of the study’s research methodology and principal
data collection activities. The third section details the research findings as they relate to each
of the four criterion outlined above and it outlines their implications for future programmatic
activities. Finally, the fourth section focuses on future directions and identifies areas for
subsequent research and action.
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Emergency contraception refers to methods women can use to prevent pregnancy following unprotected sexual
intercourse. Although there are several types of emergency contraception, this study refers specifically to the
provision of two high dose oral contraceptive tablets (each containing levonorgestrel, 250cg plus ethinyl
estradiol, 50cg) within 72 hours of intercourse followed by a further two tablets 12 hours later. This regimen is
also commonly referred to as the “Yuzpe method” of emergency contraception.

BACKGROUND
In September 1997, the Population Council’s Africa OR/TA II project launched an operations
research project entitled Enhancing Access to Family Planning Services through the
Introduction of Emergency Contraception. Implemented in two distinct phases, the project is
designed to explore a broad range of issues relating to the introduction and delivery of
emergency contraception services in a developing country context. Through the involvement
of four major providers of reproductive health services (University Teaching Hospital, the
Ministry of Health/Central Board of Health, the Planned Parenthood Association of Zambia,
and the University of Zambia) emergency contraception is now available at more than 21
health care facilities across Lusaka and the rural Copperbelt. To date, over 1,500 packets of
emergency contraception pills have been dispensed through the project.2
One critical finding of the first phase results was the degree to which sociocultural and
institutional factors limit access to emergency contraception services and to the information a
woman must have before she will seek such services out. Youth, for example, tend to eschew
traditional clinic-based settings for what they perceive to be their absence of privacy. Other
potential users, by contrast, are constrained from accessing emergency contraception because
the information they receive about it fails to reflect issues of concern to them.3
There is, however, a third kind of barrier to emergency contraception. Often referred to as a
“time barrier”, it consists of any hindrance or obstacle that delays a woman from accessing
services within the narrow 72 hour window available to her, irrespective of the institutional
channels or sources through which the product (or information about the product) was originally
obtained.
Alternative strategies for administering emergency contraception provide perhaps the most
effective means for breaking down these so-called “time barriers”. One option, recently
employed in certain developed countries, is to provide emergency contraception to women
before they ever need it. This could vary from dispensing a dedicated product (oral
contraceptives packaged exclusively for emergency contraception) to distributing coupons or
prescriptions that can be redeemed anonymously in a pharmacy or clinic dispensary.
Each of these solutions has their advocates and opponents. Family planning clients, for
example, often request packets of emergency contraception pills just so they can be “kept on
hand” in case the need arises. For these clients – many of whom live at some distance from the
health center -- prophylactic distribution represents a great convenience, both in time and cost.
2

Manufactured under the brand namePC-4, each packet of emergency contraception pills comprises four oral
contraceptive tablets containing containing levonorgestrel, 250cg plus ethinyl estradiol, 50cg.
3
Interviews carried out during the initial phase of this study suggest that women’s interests in emergency
contraception vary widely. All women express at least some concern over such issues as the potential side effects
of emergency contraception, its accessibility, and its role in protecting against STDs. But within that broad
spectrum, certain questions appear much more critical than others. Family planning users, for example, typically
showed greatest interest over the safety of emergency contraception, while non-users stood out for their curiosity
about the method itself: what it looks like, what its name is, and what form it takes. One important lesson to be
derived from these findings was the need to ensure that health care providers and developers of IEC materials
gear their communication efforts to meet the specific needs and interests of different target populations. For
more information on this issue, see Ahmed et al (1998: 13-16).
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Younger clients – particularly university students – also find prophylactic distribution attractive
insofar as it allows for greater privacy and discretion. For them, picking up emergency
contraception “in advance” offers far greater anonymity and emotional distance than doing so
when it is actually needed.
Within the health community, however, feelings towards prophylactic distribution are far more
divided. There are, it is true, many providers who see the strategy as an effective mechanism for
reducing the numbers of women who arrive at health centers too late for emergency
contraception. But there are many other providers who believe that prophylactic provision
threatens continued use of regular family planning methods. During Phase One of this study,
for example, over 12 percent of inquiries about emergency contraception related in some way to
its use as a convenient alternative to a regular contraceptive method, particularly during the
transition period between injections or before beginning a new cycle of pills. Providers were
also suspicious about distributing methods without any certainty the method would be ever be
needed or used. In a resource poor environment such as Zambia where contraceptive stockouts
are endemic and supplies are limited, the risk of “wastage” represents a powerful critique.
Among the many critics of prophylactic provision, however, are those who believe that in the
final instance, the greatest barriers to accessing emergency contraception are less related to
time and distance than they are to the lack of knowledge about the product or to the limited
range of locations where it can be obtained. What they propose, therefore, is the issuance of
advanced prescriptions that could be redeemed by clients, when needed, at any pharmacy or
clinic dispensary. If emergency contraception could be made more widely available around
the clock, they claim, there would be little need to distribute actual pills, and little need to run
the various risks associated with it.
Clearly, there are no simple answers to these contentious issues. Nor do we have – at least in a
developing country context -- concrete data capable of shedding light on them. For that reason,
the present study was designed to explore further the issue of “time barriers” and identify
strategies that might be developed to overcome them.
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OPERATIONS RESEARCH PROJECT
Launched in April 1998, the ultimate objective of this study was to explore different
approaches for overcoming barriers that prevent women from accessing emergency
contraception within the narrow 72 hour window available to them. To accomplish this, the
study assisted four public sector clinics in Lusaka (Chawama, Mtendere, Kanyama, and
Chipata) to introduce the following two strategies for administering emergency contraception:
•
•

Prophylactic distribution of emergency contraception pills.
Distribution of a printed informational card to new family planning acceptors that could
be redeemed for an actual pack of emergency contraception pills at any participating
health center.

The strategies were then compared in terms of their effectiveness at:
•
•
•
•

communicating appropriate information on emergency contraception,
reducing wastage of emergency contraception pills,
facilitating timely access to emergency contraception pills, and
limiting use of emergency contraception for emergencies only

The following describes the rationale behind each intervention and the form it took under the
present study.

Experimental Group 1: Prophylactic distribution of emergency contraception
pills
The introduction of a dedicated emergency contraception product under Phase One of this
study represented a critical first step in expanding access to emergency contraception. But it
was still an intervention that required clients to travel to a health center and explain to
someone else the circumstances leading to their current situation. Distributing pills before
they are ever needed is one way users of emergency contraception can overcome barriers of
distance and time, or even the embarrassment of confronting a provider face to face once
unprotected sex has occurred. But prophylactic distribution of emergency contraception is an
intervention whose impact is potentially complex and, in a developing country setting, largely
unpredictable. While it is reasonable to assume that having emergency contraception pills on
hand would effectively remove any remaining barriers to its use, it is not certain what the
other consequences of such a practice might be. To skeptics, it could lead to misuse of the
product, to unnecessary wastage, or even to discontinuation of one’s regular family planning
method. And even among those providers who accept the possibility that prophylactic
distribution might increase knowledge and utilization of emergency contraception, many still
question whether such increases were really worth the additional costs.
In April, 1998, prophylactic distribution of emergency contraception pills was introduced on a
limited scale at all four health centers involved in the study. Three hundred new family
planning acceptors (75 per site) were provided with a pack of emergency contraception pills
(PC-4) to take with them at the same time they received their initial family planning method.
For the purposes of this study, PC-4 was provided prophylactically only to new users of oral
4

contraceptives and condoms since these two groups were found during Phase One of the
study to be more likely than users of any other method to obtain emergency contraception.
Condom users, for example, made up only 4.6 percent of all family planning users in Phase
One, yet they accounted for almost 37 percent of emergency contraception clients. Pill users,
though obviously representing a considerably larger percentage of family planning users
overall, still accounted for a sizable 30 percent of all emergency contraception clients.
Under this intervention, each client received a packet of PC-4 (see Figure 1); was instructed
on how the pills were to be taken; the circumstances under which it was necessary to do so;
and the appropriate follow-up protocols to be followed should the recipient decide to use it4

Figure 1
Health care provider distributing emergency contraception pills prophylactically
along with a routine family planning method.

Experimental Group 2: Advanced prescription of emergency contraception
As noted previously, many in the health field question both the practicality and the utility of
prophylactic distribution. Making emergency contraception too accessible, they argue, can
present its own set of risks, particularly if it makes mis-use or even non-use of regular family
planning methods that much easier. To this group, the critical barriers affecting access to
emergency contraception are less related to factors such as time and distance than they are to
knowledge about the product or the location where it could be obtained. If emergency
contraception could be made available around the clock, they claim, the disadvantages of
distributing pills in advance would likely outweigh any advantages such a policy might
otherwise yield.
4

Under Phase One of the study, all women having received PC-4 were requested to return to the health facility
for a follow-up visit either at the resumption of their menstrual period or at any point by which time they felt
their period should have already begun. This protocol was continued under the present study.
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The second intervention to be undertaken in this project, therefore, was to introduce a strategy
that would address the concerns expressed by both proponents and opponents of prophylactic
distribution. To satisfy the informational priorities of the latter group, the project issued
prescription cards to 300 new family planning acceptors at the same time they received their
initial supply of oral contraceptives or condoms. The card contained a colored picture of a
packet of PC-4, so that it could be identified by name and sight. It included instructions on
how PC-4 was to be taken and it described the circumstances under which it was necessary to
do so. Finally, to satisfy those who were especially concerned about the embarrassment of
confronting health care providers, the card also included a statement indicating that the card
could be redeemed for an actual pack of PC-4 at the general dispensary of any one of the four
participating health centers, 24 hours a day, 7 days a week – no questions asked.
Clearly, for this intervention to work, it was necessary to ensure that emergency contraception
pills would be made available at all participating health centers on a continuous basis. Under
Phase One of this project, for example, the introduction of emergency contraception pills was
restricted exclusively to MCH/FP Departments and, by extension, to the time schedules under
which they operate: typically from 8:00 to 17:00, Monday to Friday. Anyone requiring
emergency contraception outside these hours stood little chance of obtaining it. For one
thing, few providers apart from MCH/FP staff were really familiar with emergency
contraception. And secondly, even if a client were fortunate enough to encounter a
knowledgeable provider, chances are she would still not have had access to emergency
contraception pills since they, like any other “contraceptive method”, would have been stored
exclusively in the MCH/FP unit.

Figure 2
Exchanging a prescription card for a packet of emergency contraception pills
at the OPD dispensary of a participating health center.
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To ensure that advanced prescription would indeed provide continuous access to emergency
contraception, the study assisted all four participating clinics to offer emergency
contraception pills around the clock either through MCH/FP services or, when that was
closed, through the Outpatient Department (see Figure 2). This intervention involved
familiarizing all clinic staff with the dedicated emergency contraception pill available at that
facility. It involved training those providers likely to dispense it, and it required stocking the
product in the general outpatient dispensary where it would be accessible to all clinic staff.

Control group: Routine counseling on emergency contraception
All 300 women comprising the control group were simply informed about emergency
contraception at the same time they received their initial supply of oral contraceptives or
condoms. They were shown a package of PC-4 so that it could be identified by name and
sight; and they were told how it was taken. Finally, they were told that if they should have
unprotected sex and feel they were at risk of becoming pregnant, they could return to the
current health center at any time for an actual pack of PC-4.
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STUDY DESIGN AND DESCRIPTION OF ACTIVITIES
To compare the utility and feasibility of the two new intervention strategies, the study adopted
an experimental design using three equivalent groups: two experimental (one for each
intervention) and one control. Each group consisted of 150 new acceptors of the pill and 150
new acceptors of the condom as their exclusive family planning method.5
All participants comprising the three groups were recruited over a seven week period,
between 6 June and 27 July 1998. Prior to their involvement in the study, participants were
given a brief description of the aims of the project and of the importance of completing both the
admission and follow-up interviews. After verbal and written consent had been obtained,
participants were randomly assigned to one of the three groups, in accordance with the order
in which they received their new contraceptive method (ie. the first new pill acceptor at each
clinic was assigned to Group 1, the second to Group 2, and the third to the Control Group 3,
before the process was repeated). Composition of the groups was distributed evenly among
the four participating health centers (75 subjects per clinic per Group). Age distribution of
the three groups was also comparable (see Figure 3).

Figure 3
Age Distribution of All Study Participants by Group
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DATA COLLECTION ACTIVITIES
Informational Questionnaire: At the time of admission to the study, all 900 women
completed a brief informational questionnaire. Respondents were asked to provide general
biographical information about themselves, including history of contraceptive use and earlier
5

The category of “exclusive condom users” did not include those using the condom in conjunction with another
method (dual protection). Any pill user, however, -- even those using the condom for dual protection -- would
have been included in the pill group.
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pregnancies. They were also asked to describe the circumstances surrounding any previous
history of regular unprotected sex; their sense of reproductive risk at the time; and the reasons
behind their current decision to adopt a family planning method. Finally, they were asked to
specify their current reproductive intentions: their seriousness about avoiding pregnancy and
their intentions of becoming pregnant in the future.
Follow-up Interview: At the time of admission to the study, all 900 participants were
assigned a date (approximately three months following the initial interview) when they were
expected to return to the health center for a second interview. Generally, the date
corresponded to the point at which the pill users would have been expected to return anyway
for their resupply of pills. Condom users were also scheduled to return for an interview in
three months, though many returned before that date for resupply visits.
The follow-up interview consisted of a series of questions, designed to solicit information on
the four variables by which the two intervention strategies were compared: knowledge
retention; product wastage; timeliness of access; and use for emergency purposes only. Any
woman not having reported to the health center within two weeks of the date assigned to her
was visited at home if permission had been given to do so. By the end of the study, all but 8
women had returned for follow-up.6
Focus Groups: In addition to data collected through the informational and follow-up
questionnaires, focus group discussions were held during the last month of the study. The
objective of the discussions was to understand better certain trends and patterns that emerged
from the more quantitative survey results. The discussions were also intended to gather more
detailed information on such issues as perceived risk of pregnancy among women in the
intervention groups, users’ confidence with the “self-medication” regimen entailed by the
prophylactic intervention; and finally, users’ overall perceptions of the general utility of the
intervention strategies.
Focus group participants were recruited as women reported for their follow-up interviews.
Altogether, seven focus group discussions were held during the week of 23-27 November,
1998, with at least one discussion occurring at each of the four participating health centers.
Six discussions were held with pill and condom users distributed across each of the
intervention groups. One additional focus group was held with men whose partners had used
emergency contraception.

6

In the view of project staff, the high follow-up rate could have been attributable to at least three factors. The
first was the decision by clinic staff to assign each study participant a specific follow-up appointment (verbally
and in writing) at the time they received their original family planning method. Second, because the majority of
participants came from the communities surrounding each health center, the time and effort required to return to
their respective centers was relatively minimal. In fact, during the course of the intervening three months, many
of the subjects had actually returned to the clinics for other reasons. And finally, for those who did live at a
distance from the health centers, the project agreed ahead of time to reimburse all transport costs.
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RESEARCH FINDINGS AND PROGRAMMATIC IMPLICATIONS
As noted previously, the present study compares the relative effectiveness of the three
intervention strategies in terms of the following four criteria or “impact indicators”:
•
•
•
•

communicating appropriate information on emergency contraception,
reducing wastage of emergency contraception pills,
facilitating timely access to emergency contraception pills, and
limiting use of emergency contraception for emergencies only

This chapter examines the research results collected to date under the study. The chapter is
structured by indicator, with each section addressing at least three broad issues. The first
defines each criterion operationally and explains the rationale for including it as an indicator
of each intervention’s relative impact. The second issue concerns the research findings – both
qualitative and quantitative -- as they relate to each criterion. And the third discusses the
broader programmatic implications to be derived from the research results.

10

APPROPRIATE INFORMATION
I was told all the instructions. I understood the instructions. When I was in
that situation, I took [PC-4] because I was able to recall all that [the sister]
had told me (focus group participant, Kanyama Clinic)

Within the reproductive health field, it is generally accepted that for emergency contraception
to represent a truly viable contraceptive option, women must know about it before it is
actually needed. This assumption reflects the view that unless one is already aware that
pregnancy can be avoided, the chances of discovering emergency contraception within 72
hours are minimal. But while there may be general agreement over the need for prior
knowledge, there is little agreement over just how detailed that knowledge should be or how
realistic it is to expect women to remember it. Indeed, one of the most common arguments
against prophylactic administration or even advanced prescription of emergency
contraception pills is that women will not remember how to take them correctly.
At the conclusion of the project’s first phase, therefore, health care providers agreed that in
order to access emergency contraception in a timely and appropriate manner, potential users
must at the very least be counseled to identify the following three attributes of the method: the
timeframe within which emergency contraception pills must be taken; the generic or brand
name of the product (“emergency contraception” or “PC-4”); and the location of at least one
source where the pills can be obtained. In the case of those receiving emergency
contraception pills prophylactically, providers quite naturally expected users to also know the
correct dosage of pills.7
One objective of the present study, therefore, was to gauge whether such expectations are, in
fact, reasonable and, if so, what their implications might be, both for the content of
dissemination materials on emergency contraception and for the implementation of strategies
involving prophylactic administration. The study also sought to determine whether the ways
in which emergency contraception pills were administered could themselves influence client
knowledge or their ability to recall information provided during initial counseling sessions.
Recognition of the 72 hour timeframe: During the follow-up interviews, all study
participants were asked questions regarding their general knowledge of emergency
contraception. They were asked about likely side effects, whether emergency contraception
pills could be taken before intercourse or after missing a menstrual period, and whether they
could be taken any way other than orally. Participants were also asked how long after
unprotected sex, emergency contraception pills should be taken.
In general, the participants’ knowledge and familiarity with emergency contraception was,
even after three months, exceptionally high. Over 90 percent of all women, for example,
identified correctly the time period (72 hours) within which the first dose of emergency
contraception pills had to be taken.
7

It is important to note that these criteria only represented those points on which all health care providers could
agree. The list should not be taken as an endorsement by the study as to the minimal informational requirements
of emergency contraception users.
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Correct dosage: Knowledge of the correct number of pills to be taken was also practically
universal across groups. In fact, the few incorrect responses (only six percent of all
respondents) were probably attributable to a misunderstanding of the question itself. Sixty
percent of the incorrect answers, for example, mentioned “2 pills” which is, in fact, the
correct number of pills to be taken as the first dosage during the initial 72 hours. Also
contributing to the high rate of recall may have been the brand name of the product itself.
The results of a survey carried out simultaneously among 1,600 MCH/FP clients in Lusaka
suggest that the brand name “PC-4” is already well-known in Zambia and has even become
synonymous with emergency contraception itself.
Product name: Perhaps because of such strong brand recognition, the percentage of
respondents able to identify either the name PC-4 or the expression “emergency
contraception” was not only high, but virtually identical across intervention groups. In fact,
judging from the responses to all three informational indicators discussed thus far, it seems
clear that the intervention strategies had little, if any, bearing on the ability of women to recall
what providers deemed was critical about emergency contraception.

Figure 4
Percentage of all Participants
with Correct Answers to Key Knowledge Indicators
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Supply Sources: In keeping with knowledge levels of previous indicators, the ability to
identify major sources of emergency contraception pills was also high. Respondents from all
three groups were not only familiar with the range of available supply points, but were
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equally likely to identify one or more of the correct sources: hospitals/community health
centers; private physicians; and chemists8

8

Though not involved in the present study, anecdotal information suggests that PC-4 is currently available in
Zambia through hospitals, private physicians; and chemists.
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Programmatic Implications:
In conclusion, the existing data suggest few appreciable differences among the intervention
strategies with respect to the participants’ ability to recall appropriate information about
emergency contraception. All three groups were equally likely to remember the time frame
within which emergency contraception must be initiated; the number of emergency
contraception pills needed; the frequency with which they should be taken; the name of the
emergency contraception pill; and the location where it can be obtained.
In practical terms, therefore, what these findings suggest is that fears over inadequate client
knowledge or poor recall of critical information do not represent a valid basis for doubting the
safety or practicality of dispensing emergency contraception pills, either prophylactically or
under advanced prescription. The evidence also reveals the importance of good provider
counseling and the fact that counseling alone is probably far more important in ensuring
adequate user knowledge than the particular way in which emergency contraception is
packaged and dispensed. This finding is important because it questions the need to develop
complicated or detailed instructions on how the method ought to be used. Packages of PC-4,
for example, contain an attractive 51 page booklet documenting a wide range indications,
contraindications, and licensing details.
The advanced prescription cards, by contrast
included only four basic instructions regarding dosage, timing, and suggestions to deal with
nausea and/or vomiting. Ultimately, both groups evidenced equally high knowledge about
emergency contraception.
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PRODUCT WASTAGE
I did not first hear about it from the nurse but from those who had come to
the clinic and were given PC4…
I got worried that I could be pregnant. I told my friend who gave me PC4
and I took it. (focus group participants, Kanyama Clinic).

In discussing the potential advantages and disadvantages of providing emergency
contraception pills prophylactically, one concern expressed by many providers was the
implications of distributing methods without any certainty they would be ever be needed or
used. In a resource poor environment such as Zambia where contraceptive stockouts are
endemic and supplies of all medical commodities limited, the risk of “wastage” represented a
powerful critique.
During the present study, therefore, all the women in the two experimental groups (those
receiving PC-4 in advance; and those receiving a prescription card) who never used
emergency contraception were asked during their follow-up visit whether they still had on
hand either the PC-4 packet or the prescription card (see Figure 5). Of all the women
comprising the prophylactic group, for example, 134 ended up using their packet of PC-4,
leaving 183 (58 percent) who did not. Of these 183 women, however, only 18 (10 percent)
reported not being able to remember where their unused packet of PC-4 was. The vast
majority (78 percent) either still had the pills at the time of the follow-up interview or claimed
to have had them at home. Twenty-two (12 percent) reported having “given them away” to
friends or relatives.
Figure 5
Location of unused PC-4 packets and prescription cards
(among non-users of emergency contraception)
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In the case of the 300 women who received prescription cards, only 39 or about 13 percent
ended up redeeming their cards for an actual packet of PC-4, theoretically leaving 255 women
with cards still in hand. Of these women, however, 55 (22 percent) reported not knowing the
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whereabouts of the card. Although this represented a higher percentage of loss than in the
prophylactic group, the vast majority of women (75 percent) still had the card with them at
the time of the follow-up interview or claimed to have it at home. Only 5 women (2 percent)
reported having “given it away”.
Programmatic Implications:
In the resource-poor environments that characterize much of the developing world, health
care providers have good reason to be concerned over any new intervention that might
threaten the availability of scarce equipment and supplies, including contraceptive
commodities. For reasons that are fairly self-evident, prophylactic provision of emergency
contraception pills was seen by a number of providers as one such threat.
In the case of product wastage, comparisons between prophylactic distribution and advanced
prescription are obviously complicated by the fact that only one strategy actually distributed
emergency contraception pills. The other (with the exception of those cards that were
redeemed) distributed only prescriptions. How one interprets the outcomes, therefore,
depends very much on whether one’s focus of inquiry rests with the general programmatic
consequences of losses to the service delivery system as a whole, or with the potential for
method mis-use that might result from product losses by individuals.9
As noted earlier, in the case of prophylactic provision, individual loss was fairly minimal.
Only about 10 percent of the women who did not use their emergency contraception pills, for
example, had actually lost them. But because almost half the prophylactic recipients of
emergency contraception never actually used their emergency contraception pills, loss to the
system (of unused packets) was actually quite significant. Indeed, non-use alone would
represent an overall loss to the system of over 58 percent. Obviously, the number of unused
packets of PC-4 can be expected to decrease as women have longer to use them.
Nonetheless, even studies carried out over a year suggest that losses to the system from nonuse can be significant (Glasier et al 1998).
Advance prescription, by contrast, clearly saw higher losses of the prescription cards
themselves. But unless those who reported having lost their cards had actually redeemed
them for a still unused packet of PC-4, losses to the service delivery system itself was
minimal. Indeed, even if all of those reporting lost cards had actually redeemed, but never
used them, loss to the system would still not have exceeded 22 percent.
As the following chapters reveal in greater detail, prophylactic provision of emergency
contraception pills is extremely effective at enhancing access to emergency contraception.
But it is also clear from the results of this chapter, that the routine application of such a
strategy – at least in the case of a dedicated product such as PC-4 -- would be both costly and,
from a programmatic point of view, relatively inefficient.

9

The latter might include, for example, misuse of the product by women who redeem lost cards without previous
guidance on correct method use; or indeed by anyone who might find and use lost packages of PC-4.
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TIMELY ACCESS TO EMERGENCY CONTRACEPTION SERVICES
PC-4 is good and not good at the same time. When you are on the pill, you
are very much sure that you will find the pill or get the pill from somewhere;
but the only place… [that has] PC-4 is the clinic. What would happen if
you are in the village? It is only good as long as you are close to the clinic.
(focus group participant, Mtendere Clinic)

A major objective of this study was to test the efficacy of different strategies for increasing
women’s access to emergency contraception. One critical measure of a strategy’s
effectiveness, therefore, is the degree to which it reduces the length of time between a single
act of unprotected sex and the administration of the first dose of emergency contraception
pills. For that reason, all users of emergency contraception in this study were asked during
the follow-up interview how soon after having unprotected sex they began taking PC-4.

Figure 6
Time Interval Between Unprotected Sex
and Administration of Emergency Contraception
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Although study participants were only instructed to take their first dosage of emergency
contraception pills within the 72 hours of unprotected sex, the average time interval between
these two events varied dramatically among the intervention strategies. As one might have
predicted, those women with emergency contraception pills already on hand (Prophylactic
Group) started their first dosage considerably earlier than did either of the other two groups.
As indicated above in Figure 6, nearly 80 percent of the Prophylactic Group who took PC-4,
took their first pills within 24 hours of unprotected sex.
The advanced prescription intervention, by contrast, had virtually no effect whatsoever at
decreasing the time interval between unprotected sex and the initiation of emergency
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contraception. Indeed, emergency contraception users among the prescription group were
even less likely to begin treatment within the first 24 hours than those in the control group.
This prompts one to ask then, what possible advantage “advanced prescription” might offer?
One possibility is that it offers anonymity – specifically to the extent it obviates the need to
“explain oneself” immediately after having had unprotected sex. If that were the case, then
the impact of this strategy would not be evidenced in greater timeliness of access, but in a
higher use of emergency contraception – at least relative to the control group. But as Figure 7
reveals, that did not occur either (emergency contraception users accounted for an identical 13
percent of women in both the advanced prescription and control groups). Two factors may
account for this. One was the nature of the client base involved in the study. According to
the results of the study’s first phase, those most likely to value anonymity were not regular
clients of family planning clinics (the client base of this study), but rather young and
unmarried women who often feel marginalized or even rejected by the existing service
delivery system. Consequently, if the participants involved in this study really were atypical
of that group, then one would see little or no difference in the use of emergency
contraception.10
Another explanation for the limited impact of the prophylactic intervention, however, may
have been the narrow scope and inconsistent application of the intervention itself. Under the
study, for example, clients were still required to return to a health center, even if the source of
supply was the OPD rather than MCH/FP dispensary. If anonymity were really a critical
factor in the success of advanced prescription, then a more effective assessment of its role
might have been to broaden the range of facilities where prescription cards could have been
redeemed.

Programmatic Implications:
Had all study participants been instructed to take their first dosage of emergency
contraception pills as early as possible, rather than just within 72 hours, it is quite possible
that Figure 6 would have seen at least some shift to the left on the part of all three
intervention groups. Even so, insofar as all but three emergency contraception users did
comply with the instructions given them, ultimately, the three strategies did indeed prove
equally effective at ensuring compliance with the recommended regimen.
Such figures notwithstanding, however, the very fact that almost half (44.4 percent) of PC-4
users within the Prophylactic Group – and only that group – began their pills within 12 hours
of unprotected sex, leaves little doubt that having emergency contraception pills on hand
when they are needed dramatically enhances access to them. Moreover, the importance of
such increased accessibility has recently been highlighted by research suggesting that the
efficacy of both the Yuzpe and levonorgestrel emergency contraception regimens is
“significantly and inversely related to time since unprotected coitus” (Task Force 1998: 432).
Conducted under the auspices of the WHO Task Force on Postovulatory Methods of Fertility
Regulation, the study found pregnancy rates increasing from 2 percent among those initiating
10

Even if the sample had been suitably representative, however, a more accurate assessment would have entailed
comparing all incidences of unprotected sex against those that were actually followed by emergency
contraception. The current design assumes levels of unprotected sex to be comparable across all three groups.
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emergency contraception within 24 hours of unprotected sex, to 4.1 percent among women
beginning treatment within 25-48 hours; to 4.7 percent among those initiating treatment
between 49 and 72 hours.
One clear message to emerge from these findings is that prophylactic administration of
emergency contraception pills can have a dramatic appreciable effect on reducing the length
of time between unprotected sex and the administration of the first dose of emergency
contraception pills. Though all but three emergency contraception users were ultimately able
to begin treatment within the first 72 hours, the WHO data nevertheless demonstrates that
there are indeed clear advantages to starting early. This message should be communicated to
all potential users of emergency contraception.
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USE OF EMERGENCY CONTRACEPTION FOR EMERGENCIES ONLY
I would encourage those who manufacture PC-4 because it helped me. I would like to be
taking it regularly. There are some who take Microgynon but get pregnant. By the time they
[learn they are pregnant]…, the fetus would have started making movements in the womb. I
would be happy if we were told to continue taking PC-4 and stop taking Microgynon (focus
group participant, Chipata Clinic)

In many respects, the role of emergency contraception within a family planning program
represents a paradox for health care providers. Under ordinary circumstances, for example, the
increased usage of a contraceptive method would readily be seen as a sign of a success. But in
the case of emergency contraception, increased usage is often seen as a sign of program failure.
How can this paradox be explained?
For one thing, it is often argued that despite the relative efficacy of emergency contraception, it
is a method that has certain drawbacks. It requires prior user-awareness; it has a short window
of opportunity; it is less effective than many routine contraceptives and it can have unpleasant
side effects It is, in the eyes of many, a method that ought to remain precisely what its name
suggests, "emergency". Further, the argument is often made that if counseling were adequate,
and method selection appropriate, then barring unforeseen accidents such as condom breakage
or rape, there ought to be little need for emergency contraception in the first place.
The paradox surrounding emergency contraception, therefore, is the fear that the greater one’s
access to it becomes, the less likely it will be used for emergencies. Indeed, one of the
arguments put forward by health care providers during Phase One of this study was that
prophylactic distribution of emergency contraception would encourage women to abandon
regular family planning under the belief that emergency contraception would always be there “in
an emergency”. After all, they pointed out, over 12 percent of all inquiries about emergency
contraception related in some way to the use of emergency contraception as a convenient
alternative to a regular contraceptive method, particularly during the transition period between
injections or before beginning a new cycle of pills.
One of the most critical issues addressed during this study, therefore, was to determine whether
increased access to emergency contraception did indeed encourage non-use of routine family
methods or enhance the likelihood that it would be used for reasons other than rape, method
failure, or other unplanned acts of unprotected sex.
Research findings:
As shown in Figure 7, a comparison of the three intervention groups reveals that women with
prior access to emergency contraception pills were over three and a half times more likely to
use them than either those who received prescriptions or those in the control group. But the
critical question is whether this higher use resulted from factors attributable to having
emergency contraception pills on hand; or to the fact that having emergency contraception
pills enabled women to better deal with circumstances and needs common to all three groups.
The answer, it seems, involved both explanations.
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As to the factors affecting all groups, one of the most striking was the degree of inconsistency
in the use of routine planning methods, specifically the condom and pill. Already within the
first three months of receiving their new method, a large percentage of women reported
having forgotten to take them, having misplaced them, or simply of having abandoned them
because of side effects. Certain events, such as funerals (which typically involve travel, high
alcohol consumption, etc.), were frequently mentioned as reasons for having forgotten
methods and, subsequently, for high levels of unprotected sex. Method failure, particularly
condom breakage, was also common.

Figure 7
Percentage of Emergency Contraception Users by Group
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Given the similar patterns of poor contraceptive use across all three groups, it is clear that at
least some percentage of emergency contraception use had nothing to do with the presence,
absence, or even prior knowledge of emergency contraception pills. All women, to some
degree, abandoned methods, forgot them or misused them. In such cases, the only advantage
to accrue to the prophylactic group would have been their ability to react more quickly to the
consequences of unprotected sex. For these women, then, greater use of emergency
contraception pills could be explained in part, by their greater access to them.
But it is also clear that in addition to enhancing accessibility, prophylactic provision of
emergency contraception pills can change the environment within which contraceptive
decisions are made. In some cases, it creates pressures that would not otherwise exist; and in
others it makes it easier to respond to those pressures by abandoning routine methods in favor
of emergency contraception pills. One such change was the apparent leverage prophylactic
provision provided men in negotiating condom use with their partners. In focus group
discussions and even during follow-up interviews, women often claimed that their partners
had refused to use a condom after learning that they had had emergency contraception pills on
hand. But the focus groups also revealed the extent to which women themselves valued
emergency contraception. In some cases, they said it offered welcomed respite from what
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were often long-standing sources of domestic argument; but in others they said that it also
provided them with an opportunity to enjoy “skin-to-skin” contact.
Sometimes men become difficult to negotiate [with]. You may have been using condoms, but
when he comes he just wants to have sex. If you try to take a condom he will refuse. If you
try to take tablets, he will refuse it as well. You have no alternative but to have sex quickly
and use PC-4 (focus group participant, Kanyama Clinic).

While focus group discussions identified linkages between prophylactic provision and nonuse of condoms, perhaps even more significant was the seeming ability of prophylactic
provision to draw attention to the perceived inconveniences of other hormonal methods –
particularly the pill. Indeed, results from the follow-up questionnaire revealed that among the
prophylactic group, it was actually pill users who were more likely to use their packet of PC-4
(see Figure 8)11. Only among the control group did condom acceptors represent the majority
of emergency contraception users. What, then, were these supposed “disadvantages” of
alternative hormonal methods?

Figure 8
Contraceptive Method Mix of Emergency Contraception Users
at Time of Admission to Study
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For one thing, prophylactic provision provided women with greater opportunities to act on
perceptions and beliefs, regardless of whether those perceptions had any basis in fact. During
11

Figure 8 groups emergency contraception users by the “routine” family planning method (condom or pills)
they were given at the beginning of the study. During the interval between their admission to the study and the
point when they took PC-4, many subjects had actually switched their routine method. To assess the impact of
this switching on emergency contraception use, participants were also asked to indicate the method they were
actually using when they took emergency contraception. The results, though similar to those represented in
Figure 8, showed an even higher proportion of pill to condom users (59:34) in the prophylactic group. The
reason for this was that many original condom users had already switched to another method by the time they
had taken PC-4.
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the first phase of the study, for example, many women were attracted to emergency
contraception’s post-coital nature and simplicity of use. In fact, it was this appeal that led
many providers to fear that prophylactic provision might only encourage women to abandon
their regular methods in favor of emergency contraception. But the current phase of the study
revealed still other factors that made emergency contraception “more appealing” than the pill.
One such factor was the widespread perception that emergency contraception was actually
more effective than the pill. Though incorrect, the logic behind this argument was at least
intuitively sound: “if pregnancy can be prevented by four “emergency” pills instead of 28
regular ones, then clearly the former must be more powerful than the latter. Ironically, even
the unpleasant side effects of PC-4 were seen to be proof of its relative strength and efficacy.
Unfortunately, such views were often reinforced – albeit unwittingly -- by health care
providers. One woman, for example, reported having asked the nurse how effective PC-4
was:
… because I thought that someone may get pregnant even if it was used within a short period
of time. She explained that no one who got it from here came up with a complaint that they
had got pregnant. I am sure that was why she said it was effective (focus group participant,
Mtendere Clinic).

A similar argument was put forth by women who compared their own experience or that of
their friends who had become pregnant while taking the pill, with claims by providers that
“[so far] that has never happened with someone who was taking PC-4.” Some women (and
men) even attributed the greater efficacy of emergency contraception to its name:
What convinced me that it was very powerful was the word “emergency” and the explanation
that … it could be used in cases of rape. If a rape victim reports within 24 hours, there will
be no pregnancy. I said to myself that if that is the case, then it must be very powerful (focus
group participant, Mtendere Clinic).

One additional consequence of providing emergency contraception pills prophylactically was
the tendency it had to instill curiosity among those who received it. Though providers were
instructed to avoid sounding as though they might be encouraging use of the pills, the fact is
that many women admitted to using them precisely because they were “already there”.
Obviously, this initial curiosity, once satisfied, would not be likely to sustain itself
indefinitely. Nevertheless, the results of focus group discussions do suggest that prophylactic
administration played a notable role in encouraging at least first-time use of emergency
contraception pills.
In short, whether it was because of new pressures on women or because of greater access to
the method itself, prophylactic provision of emergency contraception pills did, to some
extent, encourage non-use of routine family planning methods for reasons other than method
failure, rape or accident. Furthermore, the data also show that once a woman’s packet of
emergency contraception pills has been used up, she is no more likely to use it again than
women who do not have a prophylactic supply. This finding was critical because it addressed
some early suspicions that the greater use of emergency contraception by the prophylactic
group might have been attributable to some factor that placed them at a higher risk of
unprotected sex and, therefore, in greater need of emergency contraception. If that were the
case, then one would still expect to find a comparatively higher use of emergency
contraception even after their initial packet of PC-4 had been used up. But the research
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shows no such pattern. Clearly, having emergency contraception pills on hand made an
important difference.
It is also worth pointing out that the current findings are supported in the literature; most
recently by a study of emergency contraception use by Glasier et al (1998). According to
Glasier’s research, women with emergency contraception pills on hand are not only more
likely to use them than those who do not, but will continue to do so irrespective of the
number of times they have used them before. As in the present study, utilization of
emergency contraception pills was compared between two groups: one consisting of women
who received emergency contraception pills prophylactically, the other of women who
received only information. As the present study showed, women in the prophylactic group
were over three times more likely to use emergency contraception than women in the control
group (47.5 percent vs. 14 percent). Such utilization rates were especially noteworthy since,
in contrast to the present study, over 60 percent of the subjects in Glasier’s study had already
used emergency contraception once before. A comparison of utilization rates between the
two studies is shown below in Figure 9.

Figure 9
Percentage of Emergency Contraception Users by Group:
Comparison of Present Study and Glasier et al (1998)
50
45
40
35
30
25
20
15
10
5
0

47.5
42

14

13

Prophylactic
Present study

Control
Glasier et al (1998)

Glasier’s data also showed, as did this study, that when members of the prophylactic group no
longer had emergency contraception pills on hand, they were no more likely to use them than
women the control group. But of the 74 women in her prophylactic group who actually
returned to the clinic for another packet (and, therefore, were the only group of “potentially
repeat users” to still have pills on hand), 27 of them, or 36.5 percent, used emergency
contraception again. And with the percentage of repeat emergency contraception users in the
control group dropping to 10 percent, the relationship between the two groups remained fairly
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constant: women with pills on hand continued to be over three times more likely to use
emergency contraception than those without.12
Programmatic Implications:
Given the fact that increased use of emergency contraception for “non-emergencies” was
associated only with prophylactic provision, it is important to ask what these findings suggest
about the utility or even appropriateness of providing emergency contraception pills
prophylactically? Does the fact that prophylactic provision results in some non-use of routine
methods argue against self-administration? Or do the benefits of having emergency
contraception pills on hand clearly outweigh the potential risks? And if those risks do exist,
then how can they best be addressed?
In the authors’ opinion, prophylactic provision of emergency contraception pills can indeed
represent a useful approach for assisting women to address the consequences of unprotected
sex. Two factors argue for this conclusion. The first is the finding that prophylactic
administration reduces dramatically the length of time between an act of unprotected sex and
the administration of the first dose of emergency contraception pills. Not only is this a clear
sign that prophylactic provision is enhancing access to the product, but this enhanced
accessibility may also very well have direct implications for the efficacy of emergency
contraception itself.
The second factor supporting prophylactic provision is the endorsement of study participants,
themselves, all of whom were virtually unanimous in wanting greater access to emergency
contraception. Although support was highest among those who had actually used emergency
contraception pills (93 percent), even non-users overwhelmingly recommended (80 percent)
that prophylactic provision be offered to all first-time users of a family planning method.
As for the risk of prophylactic provision encouraging non-use of routine family planning
methods, the issue is a complex one. In the first place, the study results showed that the
comparatively higher use of emergency contraception by the Prophylactic Group was
attributable to their better access to it and, to some extent, their over-use of it. But it also
reflected, to some extent, the comparative under-use of emergency contraception on the part
of those who lacked ready access to the appropriate pills. If indeed the ultimate objective of
service provision is to address the reproductive health needs of women, then solution to this
discrepancy should not be to reduce all family planning users to the level of those with
limited access. Rather, it should be to expand access for those whose need for emergency
contraception is perceived to be greatest, while at the same time minimizing those factors that
typically lead to its unnecessary use: unrealistic or inaccurate perceptions about its efficacy;
the belief that it represents a practical alternative to negotiating condom use; or even the
notion that all acts of unprotected sex present the same risk of pregnancy and therefore must

12

It is necessary to acknowledge that Glasier, herself, has interpreted the results of her study to suggest that
prophylactic administration is associated only with higher initial use of emergency contraception, but not higher
subsequent use. This interpretation, however, results from not having excluded two groups from her analysis of
repeat use: 1) those in the prophylactic group who never used emergency contraception even once (and
therefore, could never be classified as repeat users); and 2) those emergency contraception users in the
prophylactic group who never came back for a resupply of pills (and therefore, no longer even had pills on hand
to self-administer).
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be followed by emergency contraception13. What this study advocates, therefore, is greater
awareness on the part of providers as to the dynamics of emergency contraception use.
Training and other informational materials must be candid about the many “unintended
consequences” of emergency contraception because it is, as we have seen, a method that can
be used in variety of ways – even as a routine family planning method. With a greater
understanding of such use-dynamics, providers will be better able to anticipate how the
method is likely to be used, which in turn should assist them in providing information that
better addresses clients’ own reproductive health needs and circumstances.

13

The present study did not record when, during the subject’s menstrual cycle, emergency contraception was
taken. It is quite possible that the greater utilization of emergency contraception by the prophylactic group
reflected the comparative ease with which the pills could be taken, even though the actual risk of pregnancy was
minimal. By contrast, those who did not already have pills may have been more selective in their use of
emergency contraception and restricted its use to those acts where the risk of pregnancy was felt to be highest.
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FROM RESEARCH TO ACTION: THE NEXT STEPS
The results of this study have documented both the strengths and weaknesses of two strategies
for enhancing access to emergency contraception. They have illustrated the ability of
prophylactic provision to reduce the time between unprotected sex and the administration of
emergency contraception pills; and they reveal the benefits of advanced prescription,
particularly its reduction in wastage. But as positive as the study results have been in general,
they also highlight certain realities associated with the adoption of these two strategies. They
reveal how prophylactic provision may increase non-use of routine family planning methods;
and they point to the need for expanding provider awareness of the dynamics of emergency
contraception use.
The challenge that lies ahead, therefore, is to explore ways of incorporating these findings
into the design and implementation of actual service delivery programs. It is one thing to
recommend greater provider awareness of the use-dynamics of emergency contraception, but
quite another to suggest how best this might this be achieved -- particularly since provider
counseling of even routine methods often remains so poor. In many respects, this study and
the research leading to it has shown precisely how complex emergency contraception can be.
It can take various forms: either dedicated products or various combinations of existing oral
contraceptives. Because it is post-coital, it can be administered in advance like most other
methods, or it can be provided afterwards. And unlike most other contraceptives (with the
exception of the condom), emergency contraception is usually expected to supplement rather
than replace more routine family planning methods. All of these issues confront service
providers as they seek to introduce emergency contraception into their routine service
delivery programs. There is no question that providers must be better equipped to anticipate
how the method is likely to be used. The real issue, however, is how can this best be
achieved?
One approach inspired by the work of an ongoing WHO Task Force on Technologies for
Fertility Regulation is to use the introduction of a new method as a means for improving the
quality of reproductive health services overall (Simmons et al 1997: 88). In many respects,
emergency contraception represents an ideal candidate for such an exercise precisely because
it is designed to supplement rather than replace existing contraceptive technologies. What
this means is that many of the service delivery attributes deemed essential for the provision of
emergency contraception would also be directly applicable to the delivery of technologies it
would be expected to supplement. This is especially critical in the case of emergency
contraception because any additional investment in training or improved services would not
just benefit the quality that method, but of all methods in general.
A second important issue to emerge from the present study is the applicability of prophylactic
provision itself. Research results have clearly shown that providing pills before they are
needed is both effective and safe. But it would be, without a doubt, both costly and
impractical to implement such a strategy for all first-time family planning users. Even if
product wastage were less than the minimal levels already suggested, the fact of the matter is
that most women who receive emergency contraception prophylactically will never actually
use it. This poses the question, then, as to when, under what circumstances, and for whom
prophylactic administration would be most appropriate. It also raises concerns over the form
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prophylactic provision might take. Should it be restricted to dedicated products where the
risk of incorrect usage is presumably less? Or should health care planners explore the
possibility of cutting up existing cycles of oral contraceptives? And if the latter is chosen,
then who would do the “cutting”? Providers or the users at home?
The last issue to be addressed is the need to explore further the role of advanced prescription
in enhancing access to emergency contraception services. This is important because in many
respects, advanced prescription has the potential of offering many of the same advantages as
prophylactic prescription, but at a considerably lower cost to the system. It can reduce the
timeframe between unprotected sex and the first dosage of emergency contraception pills by
eliminating the need for counseling precisely when time is at a premium. It offers privacy
insofar as it avoids the potential embarrassment of having to “explain oneself” before a health
care provider. It eliminates the threat (however minimal) of wastage since the method itself is
only distributed when needed. And because the cost is marginal, advanced prescription could
be routinely implemented for all first time family planning users – at least those within easy
reach of a chemist, dispensary or other outlet of contraceptive products.
In short, the time has come to move beyond asking whether alternative distribution strategies
make sense; and instead focus on discovering how the lessons of this study can finally be
brought to scale. This will entail some future research and perhaps, on occasion some
ongoing debate. But most important, it will require a commitment on the part of Zambia’s
health care providers and planners to acknowledge the potential role of emergency
contraception and broaden its availability so that it is finally within the reach of all women.
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